I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
First-line nivolumab plus ipilimumab versus chemotherapy fo..:
Scherpereel, Arnaud
;
Antonia, Scott
;
Bautista, Yolanda
...
info:eu-repo/semantics/altIdentifier/pmid/35367910. , 2022
Link:
https://hdl.handle.net/11383/2142154
RT Journal T1
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743
UL https://suche.suub.uni-bremen.de/peid=base-ftuninsubriairis:oai:irinsubria.uninsubria.it:11383_2142154&Exemplar=1&LAN=DE A1 Scherpereel, Arnaud A1 Antonia, Scott A1 Bautista, Yolanda A1 Grossi, Francesco A1 Kowalski, Dariusz A1 Zalcman, Gérard A1 Nowak, Anna K A1 Fujimoto, Nobukazu A1 Peters, Solange A1 Tsao, Anne S A1 Mansfield, Aaron S A1 Popat, Sanjay A1 Sun, Xiaowu A1 Lawrance, Rachael A1 Zhang, Xiaoqing A1 Daumont, Melinda J A1 Bennett, Bryan A1 McKenna, Mike A1 Baas, Paul YR 2022 K1 Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) K1 EQ-5D K1 Immune checkpoint inhibitor K1 Immuno-oncology K1 Immunotherapy K1 Lung Cancer Symptom Scale K1 Overall survival K1 Programmed cell death (PD)-1 inhibitor K1 Quality of life K1 Symptom burden K1 Antineoplastic Combined Chemotherapy Protocol K1 Human K1 Ipilimumab K1 Nivolumab K1 Patient Reported Outcome Measure K1 Lung Neoplasm K1 Mesothelioma K1 Malignant JF info:eu-repo/semantics/altIdentifier/pmid/35367910 LK http://dx.doi.org/https://hdl.handle.net/11383/2142154 DO https://hdl.handle.net/11383/2142154 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)